|
One aspect of our strategy is to enter into collaboration agreements, such as joint developments and licensings, with small biotech and big pharma companies.
By establishing an international presence we have laid the foundation for global marketing of acquired and in-licensed products as well as products from our in-house project portfolio.
|
We plan to continue our
geographical expansion
and increase the number
of marketed products
through additional
marketing and distribution
agreements as well as
selective acquisitions of
product rights or companies
with product portfolios and commercial infrastructure.
|
|
|
|
|
| Peder Walberg |
 |
|
"Combining great skills, finding unique solutions,
creating value for patients.
We are guided by strong
commitment and respect
in all partnerships and
collaborations.”
Peder Walberg, Vice President and Head of Business Development & Strategy |
 |
| Facts |
| Biovitrum offers full capabilities from authority interactions and clinical trials to international brand development and medical marketing. |
 |
| |
|
